XCXuanli Chen

Xuanli Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuanli Chen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Jiadong Chu

    Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University , Suzhou , China

    4 shared publications
  • Na Sun

    Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University , Suzhou , China

    4 shared publications
  • Qiang Han

    Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University , Suzhou , China

    4 shared publications
  • Qida He

    Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University , Suzhou , China

    4 shared publications
  • Tongxing Li

    Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University , Suzhou , China

    4 shared publications
  • Wei Hu

    Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University , Suzhou , China

    4 shared publications

Latest Publications

  • Bidirectional Association Between Multimorbidity and Frailty and the Role of Depression in Older Europeans

    by Zhaolong Feng, Ze Ma, Wei Hu, Qida He, Tongxing Li, Jiadong Chu, Xuanli Chen, Qiang Han, Na Sun, Yueping Shen

    Although previous studies have reported an association between multimorbidity and frailty, its direction and mechanism remain unclear. This study aimed to investigate the direction of this association, as well as the role of depression among older Europeans. We used a cross-lagged panel design to evaluate the temporal relationship between multimorbidity and frailty and the role of depression. Multimorbidity status was assessed by the self-reporting of 14 chronic diseases. Frailty was assessed based on the frailty phenotype. The European-Depression Scale (EURO-D) was used to assess depression. There was a bidirectional relationship between frailty and multimorbidity. More severe multimorbidity predicted greater frailty (β = 0.159; p < .001) and vice versa (β = 0.107; p < .001). All paths from multimorbidity to frailty were stronger than the paths from frailty to multimorbidity (b1–a1: β = 0.051; p < .001). Likewise, early multimorbidity change was a significant predictive factor for late frailty change (β = 0.064; p < .001) and vice versa (β = 0.048; p < .001). Depression in Wave 5 (T5) mediated the association between frailty in Wave 4 (T4) and multimorbidity in Wave 6 (T6; indirect effect: β = 0.004; bootstrap 95% confidence interval: 0.003, 0.006). A positive, bidirectional association was observed between multimorbidity and frailty. Depression may be a potential cause of an increased risk of multimorbidity later in life in frail older adults. Early monitoring of frailty and depression may slow the progression of multimorbidity, thereby interrupting the vicious cycle.


  • Bidirectional Associations Between Sleep Quality and Grip Strength and the Mediating Role of Depression: Evidence From Two Nationally Representative Cohorts

    by Qiang Han, Wei Hu, Na Sun, Jiadong Chu, Xuanli Chen, Tongxing Li, Qida He, Zhaolong Feng, Yueping Shen

    Although studies have demonstrated associations between sleep quality (SQ) and grip strength (GS) in older adults, the direction and underlying mechanisms of this relationship are yet to be better delineated. We aimed to longitudinally investigate the bidirectional association between SQ and GS and the mediating role of depression in this association. Based on two nationally representative samples with people aged ≥ 50 years from the China Health and Retirement Longitudinal Study (CHARLS; 4,200 participants) and English Longitudinal Study of Ageing (ELSA; 5,922 participants), cross-lagged panel models were employed to examine the potential bidirectional relationships between objectively measured GS and self-reported SQ. We observed a GS-SQ bidirectional association dominated by GS. After adjusting for potential confounders, a higher GS at T1 predicted better SQ at T2 (ELSA: β = 0.075; CHARLS: β = 0.104, P < 0.001) and vice versa (ELSA: β = 0.034; CHARLS: β = 0.030, P < 0.01). Moreover, depression partially mediated the impact of GS on subsequent SQ (ELSA, indirect effect: 0.0057, 95% CI: [0.0035-0.0084]; CHARLS, indirect effect: 0.0086, 95% confidence interval: [0.0051, 0.0131]), but not vice versa. The results regarding data from both cohorts consistently supported a bidirectional association between GS and SQ and the mediating role of depression in the dominant pathway of this bidirectional relationship. Older adults with a low GS should be made aware of a potentially vicious cycle related to depression that can affect their sleep. Regular screening for depression may help to break this cycle.


  • The Longitudinal Association Between Frailty, Cognition, and Quality of Life in Older Europeans

    by Wei Hu, Jiadong Chu, Yixian Zhu, Xuanli Chen, Na Sun, Qiang Han, Tongxing Li, Zhaolong Feng, Qida He, Jun Wu, et al.

    Evidence on the association between frailty and quality of life (QoL) is mostly limited to cross-sectional studies. Thus, the temporal order and potential mechanisms of this association are largely unknown. Our study examines both the directionality of this association and the role of cognition in this association in longitudinal data. Cross-lagged panel models were employed to examine the temporal relationship between frailty and QoL, as well as cognition’s role among 19,649 older adults in Europe. Frailty, QoL, and cognition were assessed using the health deficit index, CASP-12, and three standard cognitive tests, respectively. We observed a bidirectional association between frailty and QoL and their dynamics. High initial levels of frailty predicted poorer QoL later and vice versa (β = -0.151 and -0.052, P < 0.001). The early change in frailty predicted the late change in QoL, and vice versa (β = -0.093 and -0.061, P < 0.001). Frailty or its early change drives this interrelationship. Cognition at Wave 5 partially mediated frailty’s effect at Wave 4 on QoL at Wave 6 (indirect effect: β= -0.005, 95% CI= -0.006, -0.004). Our findings supported that early prevention of frailty, and its risk factors may have more influential protective effects on later physical and mental health, as well as the need for ongoing screening for mental health in ageing population. Also, the maintenance of good cognitive performance may help interrupt this possible vicious cycle linking frailty and QoL decline.


  • Open Access

    Associations of ultra-processed food consumption with cardiovascular disease and all-cause mortality: UK Biobank

    by Xuanli Chen, Jiadong Chu, Wei Hu, Na Sun, Qida He, Siyuan Liu, Zhaolong Feng, Tongxing Li, Qiang Han, Yueping Shen

    This study aimed to investigate the associations between ultra-processed food (UPF) consumption and the risk of cardiovascular disease and all-cause mortality in the UK Biobank Cohort. This observational prospective study evaluated 60 298 participants aged 40 years or older. We used the NOVA classification system to identify and categorize UPF. The associations among UPF consumption, cardiovascular disease (CVD) incidence and all-cause mortality were estimated using multivariable Cox proportional hazards models. Dose–response analysis of UPF consumption and CVD incidence and mortality was performed using a restricted cubic spline. After a median follow-up of 10.9 years, 6048 participants (10.0%) experienced CVD events, and 5327 (8.8%) and 1503 (2.5%) experienced coronary heart and cerebrovascular diseases, respectively. There were 2590 (4.3%) deaths, of which 384 (0.6%) deaths were caused by CVD. A higher intake of UPF was associated with a higher risk of CVD and all-cause mortality (all P < 0.001). A higher intake of UPF was associated with a higher risk of CVD [hazard ratio (HR) = 1.17, 95% confidence interval (CI): 1.09–1.26], coronary heart disease (HR = 1.16, 95% CI: 1.07–1.25), cerebrovascular disease (HR = 1.30, 95% CI: 1.13–1.50) and all-cause mortality (HR = 1.22, 95% CI: 1.09–1.36). The association of UPF consumption with a range of CVD incidents and all-cause mortality was monotonic (all P for non-linearity > 0.30). A higher proportion of UPF consumption was associated with CVD and all-cause mortality. Thus, actions to limit UPF consumption should be incorporated into the CVD and all-cause mortality prevention recommendations.